Semiconductors · Nasdaq: LRCX
Lam Research earnings: results, call transcripts & KPI history
2 quarters · fiscal year ends June · next results expected around 27 Jan 2027
Latest: Q1 FY2027
Lam Research reported record September 2026 quarter revenue of $8.22 billion, U.S. GAAP diluted EPS of $2.19, non-GAAP diluted EPS of $2.20 and U.S. GAAP operating margin of 40.0%.
Lam Research posted record results for the September 2026 quarter. Revenue was $8.22 billion, up 22% from the June quarter and 54% from a year earlier. U.S. GAAP operating margin reached 40.0%, and diluted EPS was $2.19 ($2.20 non-GAAP). Systems revenue grew fastest, led by memory, foundry and advanced packaging. China made up 35% of revenue, and operating cash flow was strong.
Quarters
KPI history
Fourth quarter worked out from the annual figure.
Data
| Q2 FY25 | $4.4B |
| Q3 FY25 | $4.7B |
| Q4 FY25 | $5.2B * |
| Q1 FY26 | $5.3B |
| Q2 FY26 | $5.3B |
| Q3 FY26 | $5.8B |
| Q4 FY26 | $6.7B * |
| Q1 FY27 | $8.2B |
Data
| Q2 FY25 | $0.92 |
| Q3 FY25 | $1.03 |
| Q1 FY26 | $1.24 |
| Q2 FY26 | $1.26 |
| Q3 FY26 | $1.45 |
| Q1 FY27 | $2.19 |
Fourth-quarter EPS appears once the press release is read; filings report it only for the full year.
Data
| Q2 FY25 | 30.5% |
| Q3 FY25 | 33.1% |
| Q4 FY25 | 33.7% |
| Q1 FY26 | 34.4% |
| Q2 FY26 | 33.9% |
| Q3 FY26 | 35.0% |
| Q4 FY26 | 37.4% |
| Q1 FY27 | 40.0% |
Data
| Q2 FY25 | $553.6M |
| Q3 FY25 | $1.0B |
| Q4 FY25 | $2.4B |
| Q1 FY26 | $1.6B |
| Q2 FY26 | $1.2B |
| Q3 FY26 | $809.8M |
| Q4 FY26 | $1.3B |
| Q1 FY27 | $3.2B |
Operating cash flow minus capital expenditure, from cash flow statements.
| Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.4B | $4.7B | $5.2Bd | $5.3B | $5.3B | $5.8B | $6.7Bd | $8.2B |
| Gross margin | 47.4% | 49.0% | 50.1% | 50.4% | 49.6% | 49.8% | 51.7% | 52.3% |
| Operating income | $1.3B | $1.6B | $1.7Bd | $1.8B | $1.8B | $2.0B | $2.5Bd | $3.3B |
| Operating margin | 30.5% | 33.1% | 33.7% | 34.4% | 33.9% | 35.0% | 37.4% | 40.0% |
| Net income | $1.2B | $1.3B | $1.7Bd | $1.6B | $1.6B | $1.8B | $2.3Bd | $2.8B |
| Diluted EPS | $0.92 | $1.03 | — | $1.24 | $1.26 | $1.45 | — | $2.19 |
| Operating cash flow | $741.9Md | $1.3Bd | $2.6Bd | $1.8B | $1.5Bd | $1.1Bd | $1.5Bd | $3.5B |
| Capital expenditure | $188.3Md | $288.1Md | $172.2Md | $185.1M | $260.9Md | $331.6Md | $188.8Md | $257.7M |
| Free cash flow | $553.6M | $1.0B | $2.4B | $1.6B | $1.2B | $809.8M | $1.3B | $3.2B |
| R&D expense | $494.9M | $525.9M | $580.2Md | $576.4M | $573.3M | $583.2M | $642.9Md | $666.4M |
From XBRL data in 10-Q and 10-K filings. d derived: a fourth quarter is the full year minus the first nine months, and cash flows are year-to-date figures differenced.
10-Q and 10-K filings
- 22 Oct 202610-Q for the period ended 27 Sep 2026SEC ↗
- 7 Aug 202610-K for the period ended 28 Jun 2026SEC ↗
- 23 Apr 202610-Q for the period ended 29 Mar 2026SEC ↗
- 29 Jan 202610-Q for the period ended 28 Dec 2025SEC ↗
- 24 Oct 202510-Q for the period ended 28 Sep 2025SEC ↗
- 11 Aug 202510-K for the period ended 29 Jun 2025SEC ↗
- 25 Apr 202510-Q for the period ended 30 Mar 2025SEC ↗
- 31 Jan 202510-Q for the period ended 29 Dec 2024SEC ↗